menu Menu Search
What are you looking for? close
RCVS Registered: 7025700
Run by a qualified team of Vets
First Class Delivery only £3.99
Next Day Delivery available
10mg Trilotab Chewable Tablets for Dogs - Pack of 30
View Larger

10mg Trilotab Chewable Tablets for Dogs - Pack of 30

953581

£50.33 (inc. VAT)

Trilotab 10mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome

10mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.

Administered orally, 10mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.

VETERINARY PRESCRIPTION REQUIRED

Product Features

add remove
  • Pack Size: - Box of 30 Tablets
  • Target Animal: - Dog (Canine)
  • Pet Prescription Required?: - Yes

More Information

add remove

Description

Cushing’s syndrome, or hyperadrenocorticism, is a prevalent endocrine disorder in dogs, particularly affecting those in middle to older age. It arises from prolonged exposure to elevated cortisol levels, a hormone produced by the adrenal glands. This condition can lead to various health issues, including increased thirst and urination, excessive appetite, abdominal enlargement, hair loss, and muscle weakness.

Understanding Cushing’s Syndrome in Dogs

Cushing’s syndrome manifests in two primary forms:

  1. Pituitary-Dependent Hyperadrenocorticism (PDH): This is the most common form, accounting for approximately 85% of cases. It results from a benign tumour in the pituitary gland at the brain's base, leading to excessive production of adrenocorticotropic hormone (ACTH). Elevated ACTH levels stimulate the adrenal glands to overproduce cortisol.

  2. Adrenal-Dependent Hyperadrenocorticism (ADH): This form is less common and occurs due to a tumour in one or both adrenal glands, causing increased cortisol production.

Common clinical signs of Cushing’s syndrome include:

  • Increased thirst and urination
  • Increased appetite
  • Abdominal distension, often referred to as a "pot-bellied" appearance
  • Hair loss, particularly on the body’s trunk
  • Thinning skin
  • Muscle weakness and lethargy
  • Panting
  • Recurrent skin infections

These symptoms develop gradually and may be mistaken for normal ageing changes. Therefore, a thorough veterinary evaluation is essential for accurate diagnosis and management.

You may also like

30 x Vetoryl 10mg Capsules - Box of 30

Vetoryl 10mg Capsules - Box of 30

10mg Vetoryl Capsules are used in the treatment of Cushing's syndrome in dogs. Vetoryl may be used for treatment of both pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. VET PRESCRIPTION REQUIRED

£52.21
30mg Trilotab Chewable Tablets for Dogs - Pack of 30

30mg Trilotab Chewable Tablets for Dogs - Pack of 30

Trilotab 30mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome

30mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.

Administered orally, 30mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.

VETERINARY PRESCRIPTION REQUIRED

£64.61
  • New
10mg Trilotab Chewable Tablets for Dogs - Pack of 30

60mg Trilotab Chewable Tablets for Dogs - Pack of 30

Trilotab 60mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome

60mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.

Administered orally, 60mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.

VETERINARY PRESCRIPTION REQUIRED

£77.92
  • New